The use of immunotherapy in patients with various types of cancer has led to dramatic increases in survival. Increased median ...
Altimmune continues developing pemvidutide for MASH but has yet to secure a partner or acquisition despite sector M&A ...
Background: Individuals with Rett Syndrome (RTT) frequently experience comorbid epilepsy. Few studies have examined the impact of epilepsy healthcare utilization using real-world datasets among RTT.
NEW YORK, Oct. 07, 2025 (GLOBE NEWSWIRE) -- Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, ...
It is also reported that Armenia and Azerbaijan have been making strong diplomatic steps toward a lasting resolution to their decades of confrontation with each other, with both countries initiating a ...
The press conference was scheduled for 2 p.m., but after a delay to 2:30, Belichick didn’t take the podium until 2:42. Last week, the Tar Heels focused on fundamentals. Belichick addressed several ...
North Carolina head coach Bill Belichick spoke to the media at the Kenan Football Center on Tuesday to discuss the upcoming matchup with Clemson, the quarterback controversy and the offensive line.
The AI medical scribe solutions market has boomed in the past year, saving physicians significant time and enhancing the quality of healthcare interactions for patients. They've proven indispensable ...
Shares of Protagenic Therapeutics Inc (NASDAQ:PTIX) are trading sharply higher Thursday afternoon, soaring over 100% midday after the company announced a key clinical milestone. What To Know: This ...
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) is one of the 11 Best Short-Term Stocks to Invest in. The company sees its Buy rating reiterated following promising results from its clinical trials, ...
In the second quarter, the firm began dosing patients in three signal-seeking clinical trials to evaluate BNT327, its VEGF x PD-L1 bispecific, in combination with antibody-drug conjugates as ...